Viral plaques and Oncolytic viruses
Plaques are clear zones formed in a lawn of cells due to lysis by phage. Lysogens begin to grow in the middle of the plaque, giving the plaque a turbid. The morphology of the plaque depends upon the phage, the host, and the growth conditions. Virus quantification is counting the number of viruses in a particular volume to determine the virus concentration. The plaque assay can be used to refine a clonal population of virus. An Oncolytic virus is a virus that specially infects and kills cancer cells. Viral oncology is concerned with treatment of human cancers / tumors with virus particles. Certainly, the infectious nature of specific tumors has important implications in their prevention, diagnosis, and therapy. In the 21st Century, the research on viral oncology field continues to be dynamic, with new significant and original studies on viral Oncogenesis and as a translational research from virology for the treatment of cancer.
- Bacteriophage viruses
- Lysogenic phages
- Oncolysis
- Stimulate host anti-tumour immune response
- Oncology Drug Advisory Committee
Related Conference of Viral plaques and Oncolytic viruses
21st International Conference on Virology, Emerging Diseases & vaccines
10th International Conference on Microbiome, Probiotics & Gut Nutrition
9th International Conference on Antimicrobial and Antibacterial Agents
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
Viral plaques and Oncolytic viruses Conference Speakers
Recommended Sessions
- Anti-virulence and Cell-mediated immunity
- Antivirals/Antimicrobials/Antifungals
- Diagnosis of infectious diseases
- Epidemiology
- Hepatitis C viruses and Neurotropic viruses
- Human papillomavirus
- Immunology of Infections
- Live, Attenuated, Inactivated, DNA vaccines
- Molecular biology
- Monoclonal antibodies
- Paleoviruses, Viral infections and Viral Replication
- Plant and Agricultural Virology
- Recent Advances in Drug Discovery
- Respiratory and Pediatric Infectious Diseases
- STD & HIV Infection
- Urinary tract infections and Vector-borne Diseases
- Viral & Microbial Pathogenesis
- Viral Life cycle and Viro therapy
- Viral plaques and Oncolytic viruses
- Virus Evolution
Related Journals
Are you interested in
- Advances in Bacteriology and Microbiology - Bacteriology-2026 (UAE)
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Animals in a Bacterial World-A New Imperative for the Life Sciences - Microbiome 2026 (USA)
- Antimicrobial Resistance and Antibiotic Alternatives - Bacteriology-2026 (UAE)
- Arbuscular Mycorrhizal Fungi (AMF) - Microbiome 2026 (USA)
- Bacterial and Microbial Genomics & Proteomics - Bacteriology-2026 (UAE)
- Bacterial Selection for Biological Control of Plant Disease - Microbiome 2026 (USA)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Bioinformatics and Microbial Data Science - Bacteriology-2026 (UAE)
- Biostimulants and Biocontrol Strategies - Microbiome 2026 (USA)
- Clinical and Neuro Virology - Virology-2026 (UK)
- Clinical Microbiology and Infectious Diseases - Bacteriology-2026 (UAE)
- Computational and AI-driven Microbiology - Bacteriology-2026 (UAE)
- Emerging infectious diseases and the "One Health" concept - Virology-2026 (UK)
- Environmental Microbiology and Bioremediation - Bacteriology-2026 (UAE)
- Epidemiology of Re-Emerging Infectious Diseases - Virology-2026 (UK)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Food Microbiology and Safety - Bacteriology-2026 (UAE)
- General Virology - Virology-2026 (UK)
- Harnessing Phytomicrobiome Signaling for Microbiome Engineering - Microbiome 2026 (USA)
- Immunization and Immunotherapeutics - Virology-2026 (UK)
- Industrial Microbiology and Biotechnology - Bacteriology-2026 (UAE)
- Influenza and other Respiratory Diseases - Virology-2026 (UK)
- Interplay Between Diet, Gut Microbiota, Epigenetic Events and Colorectal Cancer - Microbiome 2026 (USA)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Measles as re-emerging infectious disease - Virology-2026 (UK)
- Medical and Pharmaceutical Microbiology - Bacteriology-2026 (UAE)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Ecology and Evolution - Bacteriology-2026 (UAE)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Enzymes and Metabolites - Bacteriology-2026 (UAE)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Pathogenesis and Host Interactions - Bacteriology-2026 (UAE)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- Microbiome and Human Health - Bacteriology-2026 (UAE)
- Microbiome as a Human Organ - Microbiome 2026 (USA)
- Microbiome- Science Comes to Life - Microbiome 2026 (USA)
- Modulation of Microbiota - Microbiome 2026 (USA)
- New and Endogenous Retroviruses - Virology-2026 (UK)
- Novel Antiviral Therapies - Virology-2026 (UK)
- Novel Vaccine Delivery Methods - Virology-2026 (UK)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric Microbiome-Vaginal Delivery vs C-Section - Microbiome 2026 (USA)
- Plant Beneficial Microbes - Microbiome 2026 (USA)
- Plant Conditioners (Biostimulants) - Microbiome 2026 (USA)
- Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome) - Microbiome 2026 (USA)
- Signaling in the PhytoMicrobiome - Microbiome 2026 (USA)
- Skincare Products with Probiotics-Worth the Hype? - Microbiome 2026 (USA)
- STD's and Non-Viral STIs - Virology-2026 (UK)
- Structural and Molecular virology - Virology-2026 (UK)
- Synthetic and Systems Microbiology - Bacteriology-2026 (UAE)
- The Gut Microbiota - Centerpiece of Human Health - Microbiome 2026 (USA)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2026 (USA)
- The Microbiome in Cancer Development and Therapy - Microbiome 2026 (USA)
- The Microbiota in Early Life Shapes the Immune System - Microbiome 2026 (USA)
- The Skin Microbiome - Microbiome 2026 (USA)
- Transmission of Viruses - Virology-2026 (UK)
- Transplant-Associated Viral Infections - Virology-2026 (UK)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2026 (UK)
- Vaccines against tropical and neglected diseases - Virology-2026 (UK)
- Vaccines and the Microbiome - Virology-2026 (UK)
- Veterinary virology - Virology-2026 (UK)
- Viral Genetics, Evolution and Dynamics - Virology-2026 (UK)
- Viral Immunology and Immunopathology - Virology-2026 (UK)
- Viral Oncology - Virology-2026 (UK)
- Viral Pathogenesis - Virology-2026 (UK)

